BIVI - BioVie Sued By Block & Leviton LLP for Securities Law Violations | Benzinga
BOSTON, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against BioVie, Inc. (NASDAQ:BIVI) and certain of its executives, for securities fraud. The complaint was brought in United States District Court for the District of Nevada and is captioned Olmstead v. BioVie, Inc., et al., No. 3:24-cv-00035 (D. Nev.) and is brought on behalf of investors that incurred damages on their purchases in BioVie, Inc. securities between August 5, 2021 and November 29, 2023, inclusive.
A class has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
Investors who purchased BioVie, Inc. shares between August 5, 2021 and November 29, 2023 and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or to visit our website for information on the case.
The deadline to seek appointment as lead plaintiff is March 19, 2024.
What is this all about?
On November 29, 2023, BioVie, Inc. issued a press release accompanying an investor presentation disclosing top line data from its clinical trial of NE3107 for the treatment ...